Total Assets (Quarterly) Chart

Historical Total Assets (Quarterly) Data

View and export this data back to 2018. Start Trial.
Date Value
June 30, 2026 125.03M
March 31, 2026 132.92M
December 31, 2025 143.01M
September 30, 2025 157.73M
June 30, 2025 166.38M
March 31, 2025 176.24M
December 31, 2024 122.64M
September 30, 2024 137.90M
June 30, 2024 149.99M
March 31, 2024 142.52M
December 31, 2023 158.57M
September 30, 2023 172.38M
June 30, 2023 119.88M
March 31, 2023 135.58M
December 31, 2022 156.26M
September 30, 2022 180.42M
Date Value
June 30, 2022 198.83M
March 31, 2022 219.48M
December 31, 2021 247.68M
September 30, 2021 274.13M
June 30, 2021 287.88M
March 31, 2021 313.26M
December 31, 2020 329.67M
September 30, 2020 346.44M
June 30, 2020 349.45M
March 31, 2020 362.80M
December 31, 2019 158.30M
September 30, 2019 80.73M
June 30, 2019
March 31, 2019
December 31, 2018 51.83M

Total Assets Definition

Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.

Read full definition.

Total Assets (Quarterly) Range, Past 5 Years

View Total Assets (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Assets (Quarterly) Benchmarks

View Total Assets (Quarterly) Benchmarks
Start Trial
Agenus, Inc. 172.69M
Amgen, Inc. 95.64B
BioCryst Pharmaceuticals, Inc. 557.85M
Imunon, Inc. 14.99M
Curis, Inc. 18.97M

Total Assets (Quarterly) Related Metrics